← Back to catalogue
IMPROVACUTER® Evacuated Blood Collection Tube
EUDAMEDClass IVD General (EU MDR)
Ref 623040202;Model Clot Activator Tube;Gel & Clot Activator Tube
Identity
- Trade Name
- IMPROVACUTER® Evacuated Blood Collection Tube EUDAMED
- Device Name
- Evacuated Blood Collection Tube EUDAMED
- Model / Reference
- Clot Activator Tube;Gel & Clot Activator Tube EUDAMED623040202; EUDAMED
Identifiers
- Primary DI / UDI-DI
- 06974481831429 EUDAMED
- Basic UDI-DI
- B-06974481831429 EUDAMED697448183007002W4 EUDAMED
- EMDN Code
- W050101010201 BLOOD COLLECTION, TUBES WITH ADDITIVES OR SERUM SEPARATOR EUDAMED
Classification
- Device Class
- Class IVD General EUDAMEDClass A EUDAMED
- Market of Registration
- Cyprus EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Microbial Substances
No
EUDAMED
Reagent
No
EUDAMED
Self Testing
No
EUDAMED
Near-Patient Testing
No
EUDAMED
Professional Testing
No
EUDAMED
Companion Diagnostics
No
EUDAMED
Surgical Instrument
No
EUDAMED
New Device
No
EUDAMED
IMPROVACUTER® Evacuated Blood Collection Tube by Guangzhou Improve Medical Instruments Co., Ltd. — Class IVD General — IVDR, IVDD — listed in EUDAMED
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/IVDR
European Union Active
CE/IVDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/IVDR | B-06974481831429 | Class IVD General | Active |
| EUDAMED | European Union | CE/IVDD | B-06974481831429 | Class IVD General | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Guangzhou Improve Medical Instruments Co., Ltd
- EUDAMED SRN
- CN-MF-000006536
- Authorised Representative
- Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001
Sources (2)
- EUDAMED 8c985c9c-3725-493f-a00d-2cd3f46b39c9 61 fields · synced Oct 6, 2026
- EUDAMED 155fe013-c59c-4bf4-bc7d-bb3f305ec269 61 fields · synced May 19, 2026